Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Funny, I had to point out there was no CFO as of the last cc since no one else read that. Very few read the financials on this board. If they do, they don’t understand them.
Please respond with what I have said that is not true.
This should be a sticky to show the level of intellect on this board for all the greenie traders.
I’d like to see all other drugs Elite bought off of Nasrat that were worthless come to fruition. Sometimes investors are too emotionally attached to their trades that they ignore facts. It happens all too often on the OTC.
So many greenies here that have zero clue about financials, investing, how the OTC works (and doesn’t). So many here are way out of their league.
Lol your ability to spell validates it for you.
Lol, BTW I own my own company as well. You are out of your league dude. Yes, Oxycodone is being filed, but what else? You have no idea just like other investors. We hope there’s Vyvanse in the mix. We don’t know what has gone well and what hasn’t with R&D. We do know they have invested a massive amount of R&D over the years and failed miserably. We do know they have had several drugs approved that failed to launch for which they sold for pennies on the R&D dollar. That’s all in the 10Ks along with Mikah winding down.
You know nothing about the drugs in the pipeline. You have only heard they are needlemovers from the CEO. You don’t know the class, total market, Elite’s potential market penetration, etc. There is absolutely nothing divulged on which a stock analyst can base any reasonable new sales or growth assumption.
In fact, we can’t even forecast the impact to profitability because the company doesn’t communicate that either. This company claims to be a “serious company” and yet it still wears underroos.
Let’s ignore the fact that it sinks every single time. Look at history. It’s not perfect, but a great guide for what will happen after a nice rise in PPS.
Everyone must be short the stock, except you.
Putting a stop to your garbage.
Most obvious one is that it doesn’t exist, but people believe anything these days. No one is short 100 million shares of ELTP. There is zero fact to even making this a rumor other than the crap thrown against the wall here.
Absolutely, we all do. You apparently missed the memo?
Please show any data on huge shorting. Skeletons are coming out of the closet along with other types. This conspiracy is laughable.
When float is big and fat, expect the stock to be depressed. There are no large investment funds holding this stock so the stock will not act as it would on other exchanges. Why act surprised unless you are trying to artificially inflate the price?
The CEO also continues to execute non-arms length transactions muddying perception from outsiders. This is not a serious company until Mikah is shown the door.
Sales are expected to improve, but what about profitability? That’s the big question out of the last cc. How about all the failed investments over the years, failed partnerships and turnstile for CFOs that just doesn’t end. There are many reasons why the stock is so depressed. Shareholders keep getting ripped a new one year after year, but how is CEO doing with Mikah? Lining his pockets.
I’d like to see the company get out of this funk, but it needs to take bigger steps than a dopamine agonist. Let’s get those BE studies moving. Oxycodone, even if accepted and approved, wouldn’t launch for a while, but there is potential significant future value. If approved, Nasrat would sit on this until legal battlefield clears. That’s not a near-term opportunity.
I don’t think anything new will come out of Aug’s cc, if they hold it on time. I’m more interested in Nov’s forward looking commentary as half of Q3 will be over and start getting a good read on the momentum. We should hit 10M top line in Q3 with a report out in Feb.
I work for a consultancy so yes, plenty of us get hired as CFOs, short-term or long-term.
I’d love to see that. It’s possible to hire temp CFO. My firm does it all the time.
Says the dude arguing with a financial and IR consultant. May need to redirect that question to yourself.
Would be great to see for sure.
Helping raise awareness for what’s to come.
Why are people buying now? There’s a high likelihood of Q1 10Q being delayed due to no CFO to sign unless they are using an external resource. A filing delay should lead to a temporary sell off.
To be expected. Nice to see larger volume day. Been a show me stock for far too long. Looking forward to seeing larger products move through pipeline.
Good start. I’m eager to see ER roll out far beyond what Lannett did.
Or is it the missing CFO formation that happens every year?
Adderalls?
“We’re a serious company and in the future won’t be responding to such questions”…
How do you have any idea what any poster holds? Absolutely clueless.
I’m pointing out the trash that needs to be taken to the curb. Nothing but conspiracy garbage. You’ll realize this one day hopefully.
Saving the quarter each time you post on this board.
Mid-Aug for Q1 (Apr-Jun) if the normal timing holds. They haven’t hired a CFO, which is a huge concern.
Your assumption that all other posters agree is incorrect, but you keep diving into that flawed logic. This board has no impact on the share price. There are just some whiners here that drive everyone crazy.
For example, the link below I assume is Jammy’s as the language and tone used is identical.
http://elitepharmaceuticals.blogspot.com/?m=1
Absolutely 100% correct. I assume you are paid to post after the initial whine.
Stop the conspiracy crap. This is just as bad.
What is the definition of insanity?
Then try reading the transcript or read along while listening.
Completely agree, but a huge failure for CEO if that’s the peak.
Except for the fact Nasrat wouldn’t even break even from where the stock price was when he started 10 years ago. That would be quite the legacy. Long-term shareholders hosed and yet how many millions has he made off Mikah deals and crap sandwich he gave to Elite for millions and millions of shares.
Why would Nasrat act based on your 4 million share ownership ahead of his much larger stake?
Welcome back? That post was from 3 years ago.
We’re 3 weeks away from next cc. Very little is ever divulged during the Q1 call beyond what was laid out during year end call. We’ll be half way through Q2 so will be interesting to see if company is still tracking to 8-9M. Looking forward to seeing impact to margins as overhead has increased on lower sales base. Hoping close to a wash vs pre-Lannett until top line can grow.
Disregard. I see it well below current bid. Hopefully a new floor. Little volume these days.